RxDoctor Payments Data

Deepak Awasthi, MD

Neurological Surgery · Thibodaux, LANPI 1982663340

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (29.7%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Spineology Inc. accounts for 87.7% of it on its own, with 32 other manufacturers making up the rest. Reporting peaked in 2022 at $10,941 and has fallen 96.0% since, to $438 in 2025.

$21,866in general payments, 2019–2025

Across 80 payments — averaging $273.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Spineology Inc.$19K
  • Johnson & Johnson$535
  • Si-bone, Inc.$422
  • 4web, Inc.$210
  • Choice Spine, LLC$150
  • Orthofix Medical, Inc.$130
  • plus $1K from 27 others
$600in research payments, 2019–2025

Across 1 payment — averaging $600.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Spineology Inc.$600

What the payments were for

  • Consulting fees$6,25029%
  • Speaking & faculty fees$6,50030%
  • Travel & lodging$4,46320%
  • Food & beverage$4,61321%
  • Entertainment$400%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$21,866 in reported general payments places this provider in the 70th percentile of 116 neurological surgery providers in Louisiana.

See all neurological surgery providers in Louisiana

Medicare billing

Part B allowed, 2024
$94,016
Medicare patients
118
Services billed
270

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin20$193
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen17$111

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Thibodaux

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →